Personal information

Other IDs

Scopus Author ID: 24366348000

Countries

Poland

Activities

Collapse all

Works (30)

Essential thrombocythaemia progression to the fibrotic phase is associated with a decrease in JAK2 and PDL1 levels

Annals of Hematology
2022-12 | Journal article
DOI: 10.1007/s00277-022-05001-8
Contributors: Krzysztof Lewandowski; Zuzanna Kanduła; Michał Gniot; Edyta Paczkowska; Paulina Maria Nawrocka; Marzena Wojtaszewska; Michał Janowski; Magdalena Mariak; Luiza Handschuh; Piotr Kozlowski
Source: check_circle
Crossref

Molecular Changes in Chronic Myeloid Leukemia During Tyrosine Kinase Inhibitors Treatment. Focus on Immunological Pathways

OncoTargets and Therapy
2022-10 | Journal article
DOI: 10.2147/OTT.S371847
Contributors: Michał Janowski; Zofia Ulańczyk; Karolina Łuczkowska; Anna Sobuś; Dorota Rogińska; Ewa Pius-Sadowska; Michał Gniot; Krzysztof Kozłowski; Krzysztof Lewandowski; Grzegorz Helbig et al.
Source: check_circle
Crossref

DBFE: Distribution-based feature extraction from copy number and structural variants in whole-genome data

2022-02-10 | Preprint
DOI: 10.1101/2022.02.09.479712
Contributors: Maciej Piernik; Dariusz Brzezinski; Pawel Sztromwasser; Klaudia Pacewicz; Weronika Majer-Burman; Michal Gniot; Dawid Sielski; Alicja Wozna; Pawel Zawadzki
Source: check_circle
Crossref

Validation of HER2 Status in Whole Genome Sequencing Data of Breast Cancers with the Ploidy-Corrected Copy Number Approach

Molecular Diagnosis & Therapy
2022-01 | Journal article
DOI: 10.1007/s40291-021-00571-1
Contributors: Marzena Wojtaszewska; Rafał Stępień; Alicja Woźna; Maciej Piernik; Pawel Sztromwasser; Maciej Dąbrowski; Michał Gniot; Sławomir Szymański; Maciej Socha; Piotr Kasprzak et al.
Source: check_circle
Crossref

Validation of HER2 status in whole genome sequencing data of breast cancers with AI-driven, ploidy-corrected approach

2021-09-05 | Other
DOI: 10.1101/2021.08.30.21258379
Contributors: Wojtaszewska Marzena; Stępień Rafał; Woźna Alicja; Piernik Maciej; Dąbrowski Maciej; Gniot Michał; Szymański Sławomir; Socha Maciej; Kasprzak Piotr; Matkowski Rafał et al.
Source: check_circle
Crossref

Characterization and significance of the Philadelphia negative/BCR-ABL1 positive rearrangement or masked Philadelphia translocation in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a single-center study

Leukemia & Lymphoma
2020-01-02 | Journal article
DOI: 10.1080/10428194.2019.1648807
Contributors: Blazej Ratajczak; Michal Gniot; Anna Przybylowicz-Chalecka; Joanna Czerwinska-Rybak; Mieczyslaw Komarnicki; Krzysztof Lewandowski; Malgorzata Jarmuz-Szymczak
Source: check_circle
Crossref

Germline missense NF1 mutation in an elderly patient with a blastic plasmacytoid dendritic cell neoplasm

International Journal of Hematology
2019 | Journal article
DOI: 10.1007/s12185-019-02642-w
EID:

2-s2.0-85064342872
Contributors: Szczepaniak, A.; Machnicki, M.; Gniot, M.; Pępek, M.; Rydzanicz, M.; Płoski, R.; Kaźmierczak, M.; Stokłosa, T.; Lewandowski, K.
Source: Self-asserted source
Michal Gniot via Scopus - Elsevier

Variant-specific discrepancy when quantitating BCR-ABL1 e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assay

European Journal of Haematology
2019 | Journal article
DOI: 10.1111/ejh.13238
EID:

2-s2.0-85065256749
Contributors: Kjaer, L.; Skov, V.; Andersen, M.T.; Aggerholm, A.; Clair, P.; Gniot, M.; Soeby, K.; Udby, L.; Dorff, M.H.; Hasselbalch, H. et al.
Source: Self-asserted source
Michal Gniot via Scopus - Elsevier

Potential Leukemic Cells Engraftment After Hematopoietic Stem Cell Transplantation From Unrelated Donors With Undiagnosed Chronic Leukemia

Transplantation Proceedings
2018 | Journal article
DOI: 10.1016/j.transproceed.2018.04.036
EID:

2-s2.0-85057450437
Contributors: Kawa, M.P.; Baumert, B.; Litwińska, Z.; Gniot, M.; Pius-Sadowska, E.; Rogińska, D.; Lewandowski, K.; Zdziarska, B.; Machaliński, B.
Source: Self-asserted source
Michal Gniot via Scopus - Elsevier

Coexistence of JAK2 or CALR mutation is a rare but clinically important event in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors

International Journal of Laboratory Hematology
2018-06 | Journal article
DOI: 10.1111/ijlh.12798
Contributors: K. Lewandowski; M. Gniot; M. Wojtaszewska; Z. Kanduła; R. Becht; E. Paczkowska; E. Mędraś; E. Wasilewska; M. Iwoła
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Clonal chromosomal aberrations in Philadelphia negative cells such as monosomy 7 and trisomy 8 may persist for years with no impact on the long term outcome in patients with chronic myeloid leukemia

Cancer Genetics
2017 | Journal article
DOI: 10.1016/j.cancergen.2017.04.066
EID:

2-s2.0-85032454113
Contributors: Wasilewska, E.M.; Panasiuk, B.; Gniot, M.; Sawicka, A.; Kozłowska, K.; Lewandowski, K.; Kłoczko, J.; Midro, A.T.
Source: Self-asserted source
Michal Gniot via Scopus - Elsevier

A multicenter prospective study on efficacy and safety of imatinib generics: A report from Polish Adult Leukemia Group imatinib generics registry

American Journal of Hematology
2017-07 | Journal article
DOI: 10.1002/ajh.24748
Contributors: Tomasz Sacha; Joanna Góra-Tybor; Monika Szarejko; Grażyna Bober; Olga Grzybowska-Izydorczyk; Joanna Niesiobędzka-Krężel; Marek Dudziński; Ewa Wasilewska; Krzysztof Myśliwiec; Justyna Gil et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

B-cell chronic lymphocytic leukemia with 11q22.3 rearrangement in patient with chronic myeloid leukemia treated with imatinib

Case Reports in Medicine
2016 | Journal article
DOI: 10.1155/2016/9806515
EID:

2-s2.0-85032440005
Contributors: Lewandowski, K.; Gniot, M.; Lewandowska, M.; Wache, A.; Ratajczak, Bł.; Czyz, A.; Jarmuz-Szymczak, M.; Komarnicki, M.
Source: Self-asserted source
Michal Gniot via Scopus - Elsevier

Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale

Leukemia
2016 | Journal article
DOI: 10.1038/leu.2016.90
EID:

2-s2.0-84973097794
Contributors: Cross, N.C.P.; White, H.E.; Ernst, T.; Welden, L.; Dietz, C.; Saglio, G.; Mahon, F.-X.; Wong, C.C.; Zheng, D.; Wong, S. et al.
Source: Self-asserted source
Michal Gniot via Scopus - Elsevier

CD4+CD8+ lymphocytosis and pleural and pericardiac effusions in a patient with chronic myelogenous leukemia in chronic phase treated with dasatinib due to imatinib failure,Limfocytoza CD4+CD8+ oraz wysięki osierdziowy i opłucnowy u chorego na przewlekłą białaczkę szpikową w fazie przewłeklej leczonego dazatynibem z powodu niepowodzenia terapii imatynibem

Hematologia
2015 | Journal article
DOI: 10.5603/Hem.2015.0041
EID:

2-s2.0-84957889503
Contributors: Lewandowski, K.; Lehman-Kopydłowska, A.; Gniot, M.; Czyz, A.; Ratajczak, B.; Komarnicki, M.
Source: Self-asserted source
Michal Gniot via Scopus - Elsevier

Deep molecular response after 3<sup>rd</sup>-line dasatinib treatment in patient with chronic myelogenous leukemia in chronic phase,Głęboka odpowiedź molekularna po podaniu dazatynibu w 3. linii terapii u chorego na przewlekłą białaczkę szpikową w fazie przewlekłej

Hematologia
2015 | Journal article
DOI: 10.5603/Hem.2015.0031
EID:

2-s2.0-84938871101
Contributors: Lewandowska, M.; Gniot, M.; Ratajczak, B.; Jarmuz-Szymczak, M.; Lewandowski, K.
Source: Self-asserted source
Michal Gniot via Scopus - Elsevier

Pretransplantation use of the second-generation tyrosine kinase inhibitors has no negative impact on the HCT outcome

Annals of Hematology
2015 | Journal article
DOI: 10.1007/s00277-015-2457-1
EID:

2-s2.0-84941994041
Contributors: Piekarska, A.; Gil, L.; Prejzner, W.; Wiśniewski, P.; Leszczyńska, A.; Gniot, M.; Komarnicki, M.; Hellmann, A.
Source: Self-asserted source
Michal Gniot via Scopus - Elsevier

Transient presence of clonal chromosomal aberrations in Ph-negative cells in patients with chronic myeloid leukemia remaining in deep molecular response on tyrosine kinase inhibitor treatment

Cancer Genetics
2014 | Journal article
DOI: 10.1016/j.cancergen.2014.10.003
EID:

2-s2.0-84919876561
Contributors: Gniot, M.; Lewandowski, K.; Ratajczak, B.; Lewandowska, M.; Lehmann-Kopydłowska, A.; Jarmuz-Szymczak, M.; Komarnicki, M.
Source: Self-asserted source
Michal Gniot via Scopus - Elsevier

Esterase D and gamma 1 actin level might predict results of induction therapy in patients with acute myeloid leukemia without and with maturation

Medical Oncology
2013 | Journal article
DOI: 10.1007/s12032-013-0725-2
EID:

2-s2.0-84891881398
Contributors: Kazmierczak, M.; Luczak, M.; Lewandowski, K.; Handschuh, L.; Czyz, A.; Jarmuz, M.; Gniot, M.; Michalak, M.; Figlerowicz, M.; Komarnicki, M.
Source: Self-asserted source
Michal Gniot via Scopus - Elsevier

Bortezomib has little ex vivo activity in chronic myeloid leukemia: Individual tumor response testing comparative study in acute and chronic myeloid leukemia

Wspolczesna Onkologia
2012 | Journal article
DOI: 10.5114/wo.2012.29286
EID:

2-s2.0-84865077574
Contributors: Styczyński, J.; Gil, L.; Czyzd, K.; Kołodziej, B.; Kuryło-Rafińska, B.; Lewandowski, K.; Gniot, M.; Lewandowska, M.; Komarnicki, M.; Wysocki, M.
Source: Self-asserted source
Michal Gniot via Scopus - Elsevier

K356dup - an in-frame insertion in the BCR-ABL gene in an imatinib-resistant chronic myeloid leukemia

International Journal of Laboratory Hematology
2012 | Journal article
DOI: 10.1111/j.1751-553x.2012.01443.x
EID:

2-s2.0-84873300334
Contributors: Gniot, M.; Wasilewska, E.M.; Lewandowski, K.
Source: Self-asserted source
Michal Gniot via Scopus - Elsevier

Nilotinib induced complete molecular response in the patient in chronic phase of chronic myeloid leukemia and imatinib intolerance after acetaminophen intake,Całkowita remisja molekularna po podaniu nilotynibu u chorej na przewlekła{ogonek} białaczke{ogonek} szpikowa{ogonek} w fazie przewlekłej z objawami nietolerancji imatynibu po zażyciu acetaminofenu

Hematologia
2011 | Journal article
EID:

2-s2.0-84871750242
Contributors: Lewandowska, M.; Gniot, M.; Lewandowski, K.
Source: Self-asserted source
Michal Gniot via Scopus - Elsevier

[Standardization of quantitative detection of BCR-ABL gene expression by RQ-PCR in patients with chronic myeloid leukemia in cooperation with European Leukemia Net].,Standaryzacja ilościowej oceny ekspresji genu BCR-ABL metoda RQ-PCR u chorych na przewlekła białaczke szpikowa we współpracy z European Leukemia Net.

Przegla̧d lekarski
2010 | Journal article
EID:

2-s2.0-80053642061
Contributors: Sacha, T.; Zawada, M.; Czekalska, S.; Florek, I.; Mueller, M.; Gniot, M.; Jaźwiec, B.; Kyrcz-Krzemień, S.; Leszczyńska, A.; Lewandowski, K. et al.
Source: Self-asserted source
Michal Gniot via Scopus - Elsevier

Megakaryocytic blast crisis in a chronic myeloid leukemia patient with a rare variant of Philadelphia rearrangement t(9;22;22) and a constitutional translocation t(3;7)

Cancer Genetics and Cytogenetics
2010 | Journal article
DOI: 10.1016/j.cancergencyto.2010.01.017
EID:

2-s2.0-77951927642
Contributors: Jarmuz, M.; Kroll, R.; Przybyłowicz-Chalecka, A.; Ratajczak, B.; Gniot, M.; Szyfter, K.; Komarnicki, M.
Source: Self-asserted source
Michal Gniot via Scopus - Elsevier

BCR-ABL gene mutations in CML patients treated with imatinib: Relation with clinical, cytogenetic and molecular disease progression,Mutacje onkogenu BCR-ABL u chorych z CML leczonych imatynibem: Ocena zwia̧zku z kliniczna̧ cytogenetyczna̧ i molekularna̧ progresja̧ choroby

Acta Haematologica Polonica
2009 | Journal article
EID:

2-s2.0-70450214392
Contributors: Barańska, M.; Lewandowski, K.; Gniot, M.; Lewandowska, M.; Komarnicki, M.
Source: Self-asserted source
Michal Gniot via Scopus - Elsevier

Frequency of BCR-ABL gene mutations in Polish patients with chronic myeloid leukemia treated with imatinib: A final report of the MAPTEST study

Polskie Archiwum Medycyny Wewnetrznej
2009 | Journal article
EID:

2-s2.0-75649091553
Contributors: Lewandowski, K.; Warzocha, K.; Hellmann, A.; Skotnicki, A.; Prejzner, W.; Foryciarz, K.; Sacha, T.; Gniot, M.; Majewski, M.; Solarska, I. et al.
Source: Self-asserted source
Michal Gniot via Scopus - Elsevier

Molecular and phenotypic variability in consecutive blast crises in CML patient

American Journal of Case Reports
2009 | Journal article
EID:

2-s2.0-78249243576
Contributors: Lewandowski, K.; Baranska, M.; Gniot, M.; Gil, L.; Czyz, A.; Iwola, M.; Komarnicki, M.
Source: Self-asserted source
Michal Gniot via Scopus - Elsevier

Dasatinib treatment can overcome imatinib and nilotinib resistance in CML patient carrying F359I mutation of BCR-ABL oncogene

Journal of Applied Genetics
2008 | Journal article
DOI: 10.1007/BF03195613
EID:

2-s2.0-45749156841
Contributors: Barańska, M.; Lewandowski, K.; Gniot, M.; Iwoła, M.; Lewandowska, M.; Komarnicki, M.
Source: Self-asserted source
Michal Gniot via Scopus - Elsevier

Recommendations for analysis of BCR-ABL tyrosine kinase domain gene mutations in patients with chronic meylogenous leukemia: Opinion accepted by the Polish Adult Leukemia Group,Wytyczne dotycza̧ce analizy mutacji domeny kinazy tyrozynowej genu BCR-ABL u chorych na przewlekła̧ białaczkȩ szpikowa̧: Stanowisko uzgodnione z Polish Adult Leukemia Group

Acta Haematologica Polonica
2008 | Journal article
EID:

2-s2.0-45349103099
Contributors: Sacha, T.; Lewandowski, K.; Foryciarz, K.; Gniot, M.; Szatkowski, D.; Florek, I.; Zawada, M.; Siemia̧tkowski, M.; Borycka, K.; Lewandowska, M. et al.
Source: Self-asserted source
Michal Gniot via Scopus - Elsevier

The frequency of JAK2 V617F mutation and its relation to thrombotic and bleeding episodes in patients with polycythemia vera and essential thrombocythemia

Acta Haematologica Polonica
2008 | Journal article
EID:

2-s2.0-45149090638
Contributors: Lewandowski, K.; Gniot, M.; Lewandowska, M.; Iwoła, M.; Gil, L.; Komarnicki, M.
Source: Self-asserted source
Michal Gniot via Scopus - Elsevier
How many people are using ORCID?